Form 8-K - Current report:
SEC Accession No. 0001193125-26-279803
Filing Date
2026-06-23
Accepted
2026-06-23 17:28:13
Documents
11
Period of Report
2026-06-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d133783d8k.htm   iXBRL 8-K 22223
  Complete submission text file 0001193125-26-279803.txt   132387

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enta-20260623.xsd EX-101.SCH 3174
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20260623_lab.xml EX-101.LAB 17233
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20260623_pre.xml EX-101.PRE 10808
15 EXTRACTED XBRL INSTANCE DOCUMENT d133783d8k_htm.xml XML 3539
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 261112327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)